A business in context

IMA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-14 · 0002064348-26-000003

  2. 4 · Ownership change

    Report date 2026-08-14 · 0001803794-26-000003

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-333920

  4. 8-K · Current report

    Report date 2026-08-05 · 0001193125-26-333912 · Items 2.02,9.01

  5. 4 · Ownership change

    Report date 2026-07-25 · 0001803794-26-000002

  6. 8-K · Current report

    Report date 2026-07-20 · 0001193125-26-314167 · Items 5.02,8.01,9.01

  7. 4 · Ownership change

    Report date 2026-07-16 · 0002126940-26-000004

  8. 8-K · Current report

    Report date 2026-06-22 · 0001193125-26-285424 · Items 5.02

  9. 4 · Ownership change

    Report date 2026-06-16 · 0001572451-26-000005

  10. 4 · Ownership change

    Report date 2026-06-16 · 0001555242-26-000002

  11. 4 · Ownership change

    Report date 2026-06-16 · 0001361712-26-000002

  12. 4 · Ownership change

    Report date 2026-06-16 · 0001246530-26-000004

  13. 8-K · Current report

    Report date 2026-06-16 · 0001193125-26-274139 · Items 5.02,5.07,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-212073

  15. 8-K · Current report

    Report date 2026-05-07 · 0001193125-26-211935 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-06-16 · 0001140361-26-018267

  17. 8-K · Current report

    Report date 2026-04-12 · 0001193125-26-151942 · Items 1.01,3.02,9.01

  18. 8-K · Current report

    Report date 2026-03-12 · 0001193125-26-110945 · Items 5.02

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-099434

  20. 8-K · Current report

    Report date 2026-03-10 · 0001193125-26-099422 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2026-02-12 · 0001193125-26-054684 · Items 5.02

  22. 8-K · Current report

    Report date 2025-12-12 · 0001193125-25-324798 · Items 5.02

  23. 8-K · Current report

    Report date 2025-11-19 · 0001193125-25-286984 · Items 7.01,9.01

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-275932

  25. 8-K · Current report

    Report date 2025-11-12 · 0001193125-25-275910 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2025-11-01 · 0001193125-25-266889 · Items 5.02

  27. 8-K · Current report

    Report date 2025-10-23 · 0001193125-25-254697 · Items 1.01,1.02

  28. 8-K · Current report

    Report date 2025-10-21 · 0001193125-25-245823 · Items 5.02

  29. 8-K · Current report

    Report date 2025-10-10 · 0001193125-25-237161 · Items 5.02

  30. 8-K/A · Current report

    Report date 2025-07-25 · 0001193125-25-179093 · Items 2.01,9.01

  31. 8-K · Current report

    Report date 2025-08-02 · 0001193125-25-173626 · Items 4.01,9.01

  32. 8-K · Current report

    Report date 2025-07-28 · 0001193125-25-171747 · Items 5.02,8.01,9.01

  33. 8-K · Current report

    Report date 2025-07-25 · 0001193125-25-167089 · Items 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.06,7.01,9.01

  34. 8-K · Current report

    Report date 2025-07-25 · 0001193125-25-165170 · Items 7.01,9.01

  35. 8-K · Current report

    Report date 2025-07-24 · 0001193125-25-163990 · Items 8.01

  36. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-098414

  37. 8-K · Current report

    Report date 2025-07-22 · 0001193125-25-162584 · Items 8.01

  38. 8-K · Current report

    Report date 2025-07-15 · 0001193125-25-159910 · Items 5.02

  39. 8-K · Current report

    Report date 2025-07-15 · 0001193125-25-159400 · Items 5.02,5.07,8.01,9.01

  40. 8-K · Current report

    Report date 2025-07-11 · 0001193125-25-157867 · Items 8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 2 transaction rows2SGrant / award: 6 transaction rows6AExercise / conversion: 2 transaction rows2MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

12 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-14
2026-08-17
Grant-Huerta YaninaA · Grant / award
Acquired
Common Stock39000.00.0
2026-08-14
2026-08-17
Grant-Huerta YaninaA · Grant / award
Acquired
Common Stock65000.00.0
2026-08-14
2026-08-17
Grant-Huerta YaninaA · Grant / award
Acquired
Employee Stock Option (right to buy)
Derivative security
56000.00.0
2026-08-14
2026-08-17
Yarema KristinA · Grant / award
Acquired
Common Stock254800.00.0
2026-08-14
2026-08-17
Yarema KristinA · Grant / award
Acquired
Employee Stock Option (right to buy)
Derivative security
137200.00.0
2026-08-14
2026-08-17
Yarema KristinA · Grant / award
Acquired
Employee Stock Option (Right to Buy)
Derivative security
250000.00.0
2026-07-25
2026-07-28
Yarema KristinJ · Other (see filing)
Acquired
Common Stock115129.00.0
2026-07-25
2026-07-28
Yarema KristinM · Exercise / conversion
Acquired
Common Stock38376.00.0
2026-07-25
2026-07-28
Yarema KristinJ · Other (see filing)
Disposed
Restricted Stock Units
Derivative security
115129.00.0
2026-07-25
2026-07-28
Yarema KristinM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
38376.00.0
2026-07-17
2026-07-20
Lally Robert BS · Sale
Disposed
Common Stock1525.05.34
2026-07-16
2026-07-20
Lally Robert BS · Sale
Disposed
Common Stock1671.05.5

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001835579ImageneBio, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • Ikena Oncology, Inc. · former SEC name · 2021-01-08 to 2025-07-25

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$3.50M$3.76M
2023-12-31$9.16M$10.13M
2022-12-31$15.62M$17.98M
2021-12-31$30.98M$38.52M
2020-12-31$9.19M$11.97M

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗